Mojoki BioPartners is a Pakistan-based consulting firm dedicated to empowering the pharmaceutical, biotech, and research communities across Asia, the Middle East, and beyond.
Mojoki Bio Partners is a Pakistan-based consulting firm dedicated to empowering the pharmaceutical, biotech, and research communities across Asia, the Middle East, and beyond.
To bridge science, strategy, and execution by delivering high-quality, affordable, and globally competitive consulting services that enable pharma, biotech, and research organisations to succeed in their journey from discovery to market.
Connecting global expertise with local potential.
Hours of High-End Scientific Consulting Delivered
Curated Global Network of Specialized Experts
First-Time Regulatory Compliance Success Rate
Market Access Strategy & Implementation
To bridge science, strategy, and execution by delivering high-quality, affordable, and globally competitive consulting services that enable pharma, biotech, and research organizations to succeed in their journey from discovery to market.
Your business needs consulting if you are looking to accelerate innovation, need expert guidance to navigate complex regulatory frameworks (FDA, EMA, DRAP), or require strategic insight to successfully move from discovery to market. We help organizations in Asia and the Middle East bridge the gap between scientific strategy and local execution.
Yes, we prioritize transparency and integrity in our service delivery. We offer a Free Consultation to understand your specific needs (e.g., a regulatory filing or pre-clinical study design) and then provide a detailed, project-based cost estimate before any formal engagement begins.
Our fees are structured using a flexible consulting model. We typically engage clients on a project-by-project basis, providing access to a curated network of highly specialized experts. This model ensures you receive high-quality, globally competitive expertise at an affordable and efficient rate.
Our process is built on collaboration and rigor: 1. Discovery: Free consultation to define the scope and goals. 2. Strategy: We engage the relevant experts to develop a customized strategy (scientific, regulatory, or market). 3. Execution: We deliver high-quality scientific writing, data analysis, regulatory dossiers, or market reports. 4. Impact: We focus on solutions that contribute to your better health outcomes and market success.
We specialize exclusively in the life sciences ecosystem. Our primary focus is on empowering the pharmaceutical, biotech, and research communities across Asia, the Middle East, and beyond. We translate research into commercial opportunities and bring impactful therapies to patients worldwide.
We bridge the gap between scientific discovery and market success, empowering pharma, biotech, and research communities across Asia and the Middle East to accelerate innovation and bring vital therapies to patients.
Our clients consistently praise our integrity, scientific rigor, and ability to navigate complex global regulations. We're proud to be the trusted partner that turns local potential into worldwide pharmaceutical success.
Mojoki BioPartners was instrumental in our successful DRAP registration in a record timeframe. Their specialized knowledge of local and global regulatory requirements is truly world-class. They didn't just file the paperwork; they provided the strategic rigor we needed to achieve first-time compliance.
When we decided to expand into the Middle East, Mojoki provided the clarity and insight that was missing. Their market analysis was precise, allowing us to pivot our commercial strategy effectively. They turned a daunting geographical challenge into a solid plan for commercial opportunity and portfolio growth.
The scientific depth Mojoki brings to the table is unmatched. We engaged them for pre-clinical study review, and their consultants quickly identified a critical optimization opportunity. Their collaborative model meant we had access to top-tier expertise exactly when we needed it, accelerating our R&D timeline significantly.
